Identification of Amino Acid Residues in Human IgM Fc Receptor (FcµR) Critical for IgM Binding. 2020

Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
Humoral Immune Regulation, Deutsches Rheuma-Forschungszentrum, Berlin, Germany.

Both non-immune "natural" and antigen-induced "immune" IgM are important for protection against infections and for regulation of immune responses to self-antigens. The roles of its Fc receptor (FcµR) in these IgM effector functions have begun to be explored. In the present study, by taking advantage of the difference in IgM-ligand binding of FcµRs of human (constitutive binding) and mouse (transient binding), we replaced non-conserved amino acid residues of human FcµR with mouse equivalents before establishment of cell lines stably expressing mutant or wild-type (WT) receptors. The resultant eight-different mutant FcµR-bearing cells were compared with WT receptor-bearing cells for cell-surface expression and IgM-binding by flow cytometric assessments using receptor-specific mAbs and IgM paraproteins as ligands. Three sites Asn66, Lys79-Arg83, and Asn109, which are likely in the CDR2, DE loop and CDR3 of the human FcµR Ig-like domain, respectively, were responsible for constitutive IgM binding. Intriguingly, substitution of Glu41 and Met42 in the presumed CDR1 with the corresponding mouse residues Gln and Leu, either single or more prominently in combination, enhanced both the receptor expression and IgM binding. A four-aa stretch of Lys24-Gly27 in the predicted A ß-strand of human FcµR appeared to be essential for maintenance of its proper receptor conformation on plasma membranes because of reduction of both receptor expression and IgM-binding potential when these were mutated. Results from a computational structural modeling analysis were consistent with these mutational data and identified a possible mode of binding of FcµR with IgM involving the loops including Asn66, Arg83 and Asn109 of FcµR interacting principally with the Cµ4 domain including Gln510 and to a lesser extent Cµ3 domain including Glu398, of human IgM. To our knowledge, this is the first experimental report describing the identification of amino acid residues of human FcµR critical for binding to IgM Fc.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001666 Binding Sites, Antibody Local surface sites on antibodies which react with antigen determinant sites on antigens (EPITOPES.) They are formed from parts of the variable regions of FAB FRAGMENTS. Antibody Binding Sites,Paratopes,Antibody Binding Site,Binding Site, Antibody,Paratope
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D022801 Complementarity Determining Regions Three regions (CDR1; CDR2 and CDR3) of amino acid sequence in the IMMUNOGLOBULIN VARIABLE REGION that are highly divergent. Together the CDRs from the light and heavy immunoglobulin chains form a surface that is complementary to the antigen. These regions are also present in other members of the immunoglobulin superfamily, for example, T-cell receptors (RECEPTORS, ANTIGEN, T-CELL). Complementarity Determining Region,Complementarity Determining Region 1,Complementarity Determining Region 2,Complementarity Determining Region 3,Complementarity Determining Region I,Complementarity Determining Region II,Complementarity Determining Region III,Complementarity-Determining Region,Complementarity-Determining Region 3,Hypervariable Region, Immunoglobulin,Hypervariable Regions, Immunoglobulin,Third Complementarity-Determining Region,Complementarity-Determining Region 3s,Complementarity-Determining Region, Third,Complementarity-Determining Regions,Complementarity-Determining Regions, Third,Immunoglobulin Hypervariable Region,Immunoglobulin Hypervariable Regions,Region, Complementarity Determining,Region, Immunoglobulin Hypervariable,Regions, Complementarity Determining,Regions, Complementarity-Determining,Regions, Immunoglobulin Hypervariable,Third Complementarity Determining Region,Third Complementarity-Determining Regions

Related Publications

Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
December 2024, Autoimmunity,
Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
September 1994, Virology,
Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
July 2022, Nature communications,
Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
June 1997, Brain research. Molecular brain research,
Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
August 2008, The protein journal,
Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
February 2005, Molecular pharmacology,
Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
March 2002, The Journal of biological chemistry,
Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
September 2006, Journal of pharmacological sciences,
Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
February 2015, Journal of immunology (Baltimore, Md. : 1950),
Christopher M Skopnik, and Khlowd Al-Qaisi, and Rosaleen A Calvert, and Philipp Enghard, and Andreas Radbruch, and Brian J Sutton, and Hiromi Kubagawa
March 2007, Biochemical and biophysical research communications,
Copied contents to your clipboard!